Report
Merck reportedly ordered to halt injectable Keytruda manufacture and sales in eight European markets
Reuters reports that Halozyme said a Dutch patent court ruled in its favor against Merck.
TLDR
Halozyme said a Dutch patent court ruled in its favor against Merck and ordered the drugmaker to halt the manufacture and sale of injectable Keytruda in eight European markets, Reuters reports.
Combined views
2.4K
1 Source, first seen ago